Covid-19 roundup: Moderna reportedly lacking enough minority participants; Pfizer, BioNTech and Regeneron sued for alleged patent infringement
Private contractors working for Moderna $MRNA did not enroll enough minority participants in its Covid-19 vaccine trial to determine whether or not the candidate works …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.